Tag: Molson Coors Brewing Company

  • Top News: Apple Inc. (NASDAQ:AAPL), Molson Coors Brewing Company (NYSE:TAP), Anadarko Petroleum Corporation (NYSE:APC), Weibo Corp (NASDAQ:WB), Receptos (NASDAQ:RCPT)

    Apple Inc. (NASDAQ:AAPL) newest mobile operating system, iOS 8, has code built into it that allows for apps to run simultaneously side by side something already available on Android gadgets, CNET reported. Apple Inc. (NASDAQ:AAPL) stock opened today at $94.73 and is currently trading at $94.35. The stock showed a positive weekly performance of 4.33%.

    Molson Coors Brewing Company (NYSE:TAP) British Cider has begun a promotional tour following the launch of its new cherry offering, in partnership with experiential agency Sense. Molson Coors Brewing Company (NYSE:TAP) stock opened at $67.39, in current trading session and currently is at $70.74, by gaining 5.41%. The 52 week range of $46.94 – $71.33. Company’s market capitalization is 13.09 billion.

    BP Plc (BP/) and Anadarko Petroleum Corporation (NYSE:APC) could face billions of dollars in fines after an appeals court ruled they were automatically liable for pollution-law violations as co-owners of the well that blew out and started the 2010 Gulf of Mexico oil spill. Anadarko Petroleum Corporation (NYSE:APC) stock is currently trading at $104.11. The EPS of the stock is -4.63. Company’s market capitalization is 52.58 billion.

    Equities researchers at Credit Suisse assumed coverage on shares of Weibo Corp (NASDAQ:WB) in a research report issued on Tuesday. The firm set an “outperform” rating and a $23.00 price target on the stock. Credit Suisse’s price objective would indicate a potential upside of 23.32% from the stock’s previous close. Weibo Corp (ADR) (NASDAQ:WB) stock opened the session at $19.00, and now is at $19.50. The 52 week range of the Weibo Corp (ADR) (NASDAQ:WB) stock remained $16.26 – $24.48 and the day range was $18.95 – $19.96.

    Biotech Company Receptos Inc. (NASDAQ:RCPT) jumped 39% after releasing the results of its phase 2 study. The research showed its multiple sclerosis drug reduced brain lesion activity. The Phase 3 portion of the trial began in December 2013. Receptos Inc. (NASDAQ:RCPT) stock opened today at $39.75 and is currently trading at $39.47. The stock showed a positive weekly performance of 0.65%.